Day One Biopharmaceuticals, Inc. (DAWN) Financial Ratios Annual - Discounting Cash Flows
DAWN
Day One Biopharmaceuticals, Inc.
DAWN (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Price Ratios
Price to Earnings Ratio -8.41 -12.42 -6.17 -9.91 -14.78 -35.93 -115.2
Price to Sales Ratio 9.48 9.04 0 0 0 0 0
Price to Book Ratio 2.83 2.36 3.36 4.24 3.71 38.54 -136.4
Price to Free Cash Flow Ratio -10.44 -14.78 -7.76 -12.82 -18.46 -107.2 -322.3
Price to Operating Cash Flow Ratio -10.67 -15.19 -7.93 -12.82 -21.51 -107.9 -322.3
Price Earnings to Growth Ratio 0.142 0.218 -0.356 -0.128 -0.196 -0.21 0
EV to EBITDA -5.5 -3.05 1.78 2.33 3.92 3.18
Liquidity Ratios
Current Ratio 8.68 7.66 12.72 20.94 33.43 22.58 13.53
Quick Ratio 8.55 7.61 12.72 20.94 33.43 22.58 13.53
Cash Ratio 0.766 1.7 7.82 5.13 32.84 21.91 13.52
Debt Ratio 0.006 0.004 0.001 0.002 0.001 0.009 0
Debt to Equity Ratio 0.006 0.005 0.001 0.002 0.001 0.011 0
Long Term Debt to Capitalization 0 0 0 0 0 0 0
Total Debt to Capitalization 0.006 0.005 0.001 0.002 0.001 0.011 0
Interest Coverage Ratio 0 0 0 0 0 -459.4 -7.18
Cash Flow to Debt Ratio -41.35 -30.02 -359.9 -135.1 -220.6 -33.55 0
Margins
Gross Profit Margin 89.44% 95.98% 0% 0% 0% 0% 0%
Operating Profit Margin -123.9% -165.7% 0% 0% 0% 0% 0%
Pretax Profit Margin -108.7% -67.36% 0% 0% 0% 0% 0%
Net Profit Margin -113.5% -72.81% 0% 0% 0% 0% 0%
Operating Cash Flow Margin -89.48% -59.56% 0% 0% 0% 0% 0%
Free Cash Flow Margin -90.79% -61.21% 0% 0% 0% 0% 0%
Return
Return on Assets -29.54% -16.39% -50.24% -40.73% -24.38% -88.71% -46.21%
Return on Equity -32.05% -18.99% -54.52% -42.82% -25.13% -107.3% 118.4%
Return on Capital Employed -36.22% -42.66% -59.46% -44.19% -25.87% -31.56% -58.87%
Return on Invested Capital -41.78% -61.1% 0% 0% 0% 0% 0%
Turnover Ratios
Receivables Turnover Ratio 8.01 9.45 0 0 0 0 0
Payables Turnover Ratio 2.44 1.62 0.149 2.04 0.114 0.767 0
Inventory Turnover Ratio 2 1.59 0 0 0 0 0
Fixed Asset Turnover Ratio 28.58 27.87 0 0 0 0 0
Asset Turnover Ratio 0.26 0.225 0 0 0 0 0
Per Share Items ()
Revenue Per Share 1.29 1.4 0 0 0 0 0
Operating Cash Flow Per Share -1.16 -0.834 -1.84 -1.68 -0.783 -0.218 -0.073
Free Cash Flow Per Share -1.17 -0.857 -1.88 -1.68 -0.913 -0.219 -0.073
Cash & Short Term Investments 4.37 5.68 4.59 5.23 4.59 0.706 0.441
Earnings Per Share -1.47 -1.02 0 0 0 0 0
EBITDA Per Share -1.57 -2.3 -2.58 -2.24 -1.17 -0.22 0
Dividend Per Share 0 0 0 0 0 0 0
Enterprise Value Per Share 8.62 7.02 -4.59 -5.22 -4.59 -0.7 0
Book Value Per Share 4.58 5.37 0 0 0 0 0
Price Per Share 12.96 12.67 0 0 0 0 0
Effective Tax Rate -4.46% -8.09% 0% 0% 0% 0% 0%
Short Term Coverage Ratio -743 -7,811 -359.9 -271.3 -237.9 0 0
Capital Expenditure Coverage Ratio -68.78 -36.01 -45.55 -4,226 -6.07 -146.6 0
EBIT Per Revenue -1.24 -1.66 0 0 0 0 0
EBITDA Per Revenue -1.21 -1.64 None None None None None
Days of Sales Outstanding 45.59 38.61 0 0 0 0 0
Days of Inventory Outstanding 182.6 229.6 0 0 0 0 0
Days of Payables Outstanding 149.5 225.5 2,455 178.7 3,199 475.7 0
Cash Conversion Cycle 78.78 42.69 -2,455 -178.7 -3,199 -475.7 0
Cash Conversion Ratio 0.788 0.818 0 0 0 0 0
Free Cash Flow to Earnings 0.8 0.841 0 0 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program